US5858670A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bio-oligomer libraries and a method of use thereof
Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1996-10-23
•
Granted: 1999-01-12
•
Expires: 2016-10-23
Abstract
Abstract The instant invention provides a library of bio-oligomers of defined size and known composition, in which the library contains all of the possible sequences of the bio-oligomers, and a method of synthesis thereof. The bio-oligomers of the library may be peptides, nucleic acids, or a combination of the foregoing. The instant invention also provides methods to identify bio-oligomers from a library that demonstrate desired characteristics such as binding, bioactivity and catalytic activity. Thus the instant invention provides a unique and powerful method to identify a useful bio-oligomer sequences from a library more quickly than current state-of-the-art technology allows. Effector molecules for use in treatment or diagnosis of disease are also provided.
Inventors
- 👤 Kit Sang Lam
- 👤 Sydney E. Salmon
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 02:43
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1034; C12N15/1075; C12Q; C12Q1/00; C07; C07K; C07K1/00; C07K1/04; C07K1/047; C07K14/00; C07K14/435; C07K14/665; C07K14/70; C07K14/82; C07K16/00; C07K16/18; C07K16/26; C07K16/32; C12N15/1062; A; A61; A61K; A61K38/00; A61K39/00; B; B01; B01J; B01J2219/00; B01J2219/00274; B01J2219/00583; B01J2219/00585; B01J2219/0059; B01J2219/00592; B01J2219/0068; B01J2219/00702; B01J2219/00718; B01J2219/0072; B01J2219/00722; B01J2219/00725; B01J2219/00729; C07K2317/00; C07K2317/30; C07K2317/34; C07K2317/90; C07K2317/92; C40; C40B; C40B40/00; C40B40/04; C40B40/06; C40B40/10; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55; Y10; Y10S; Y10S530/00; Y10S530/806; Y10S530/81; Y10S530/812; Y10S530/815; Y10S530/817
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
102 words
A method for determining the chemical structure of a bio-oligomer ligand for an acceptor molecule comprising the steps of: (a) introducing to a library of bio-oligomers attached to solid phase supports wherein each solid chase support is attached to a single wholly deprotected bio-oligomer species, an acceptor molecule of interest such that said acceptor molecule will recognize and bind to one or more solid phase support/bio-oligomer species within the library; (b) isolating a solid phase support/bio-oligomer combination that exhibits binding with the acceptor molecule; and (c) determining the chemical structure of the bio-oligomer of the solid phase support/bio-oligomer isolated in step (b).
Claim 2
Independent Claim
102 words
A method for determining the chemical structure of a bio-oligomer ligand for an acceptor molecule comprising the steps of: (a) introducing to a library of bio-oligomers attached to solid phase supports wherein each solid chase support is attached to a single wholly deprotected bio-oligomer species, an acceptor molecule of interest such that said acceptor molecule will recognize and bind to one or more solid phase support/bio-oligomer species within the library; (b) isolating a solid phase support/bio-oligomer combination that exhibits binding with the acceptor molecule; and (c) determining the chemical structure of the bio-oligomer of the solid phase support/bio-oligomer isolated in step (b).
Claim 3
Dependent Claim
31 words
The method of claim 1 in which the acceptor molecule is selected from the group consisting of antibodies, receptors, viruses, bacteria, proteins, carbohydrates, nucleic acids, lipids, drugs, metals and small molecules.
Claim 4
Dependent Claim
14 words
The method according to claim 2 in which the acceptor molecule is an antibody.
Claim 5
Dependent Claim
14 words
The method according to claim 2 in which the acceptor molecule is a receptor.
Claim 6
Independent Claim
312 words
A method for determining the chemical structure of a biologically active bio-oligomer ligand comprising the steps of: (a) subdividing a bio-oligomer library comprising a multiplicity of solid phase supports, wherein a single deprotected bio-oligomer species is attached to each solid phase support, and in which the library is prepared by a method comprising repeating k times, wherein k is at least three, the steps of: (i) providing at least two aliquots of a solid phase support, in which the solid phase support comprises a linker selected from the group consisting of a selectively cleavable linker, a plurality of selectively cleavable linkers, or a combination of a non-cleavable linker and a selectively cleavable linker, by means of which the bio-oligomer can be attached covalently; (ii) separately introducing a species of subunits of the bio-oligomers to each of the aliquots of solid phase supports such that a different subunit is introduced to each aliquot, at least one of said subunits having a protecting group or a plurality of protecting groups; (iii) completely covalently coupling the subunit to the reactive sites of the solid phase support; (iv) thoroughly mixing and deprotecting the aliquots of the solid phase supports whereby a reactive site is provided; and, after repeating steps (ii) through (iv) k times, a final step of removing any protecting groups such that the deprotected bio-oligomer remains covalently attached to the solid phase supports in which the solid phase support is modified so that a portion of bio-oligomer can be released; (b) releasing a portion of the bio-oligomers from the solid phase support/bio-oligomer by cleavage of a clearable linker; (c) detecting the biological activity of the released bio-oligomer interest in situ; (d) isolating a solid phase support/bio-oligomer combination that exhibits the specific biological activity of interest; and (e) determining the chemical structure of the bio-oligomer remaining on the solid phase support/bio-oligomer isolated in step (d).
Claim 7
Independent Claim
312 words
A method for determining the chemical structure of a biologically active bio-oligomer ligand comprising the steps of: (a) subdividing a bio-oligomer library comprising a multiplicity of solid phase supports, wherein a single deprotected bio-oligomer species is attached to each solid phase support, and in which the library is prepared by a method comprising repeating k times, wherein k is at least three, the steps of: (i) providing at least two aliquots of a solid phase support, in which the solid phase support comprises a linker selected from the group consisting of a selectively cleavable linker, a plurality of selectively cleavable linkers, or a combination of a non-cleavable linker and a selectively cleavable linker, by means of which the bio-oligomer can be attached covalently; (ii) separately introducing a species of subunits of the bio-oligomers to each of the aliquots of solid phase supports such that a different subunit is introduced to each aliquot, at least one of said subunits having a protecting group or a plurality of protecting groups; (iii) completely covalently coupling the subunit to the reactive sites of the solid phase support; (iv) thoroughly mixing and deprotecting the aliquots of the solid phase supports whereby a reactive site is provided; and, after repeating steps (ii) through (iv) k times, a final step of removing any protecting groups such that the deprotected bio-oligomer remains covalently attached to the solid phase supports in which the solid phase support is modified so that a portion of bio-oligomer can be released; (b) releasing a portion of the bio-oligomers from the solid phase support/bio-oligomer by cleavage of a clearable linker; (c) detecting the biological activity of the released bio-oligomer interest in situ; (d) isolating a solid phase support/bio-oligomer combination that exhibits the specific biological activity of interest; and (e) determining the chemical structure of the bio-oligomer remaining on the solid phase support/bio-oligomer isolated in step (d).
Claim 8
Dependent Claim
23 words
The method according to claim 5 in which the solid support is modified to be acid-sensitive, base-sensitive, nucleophilic-sensitive, photosensitive, electrophilic-sensitive, oxidation-sensitive, or reduction-sensitive.
Claim 9
Dependent Claim
25 words
The method according to claim 5 in which the solid phase support comprises a linker which is acid-sensitive, base-sensitive, nucleophilic-sensitive, electrophilic-sensitive, photosensitive, oxidation-sensitive, or reduction-sensitive.
Claim 10
Dependent Claim
26 words
The method according to claim 5 in which the in situ release of step (b) is affected by enzymatic cleavage, chemical clevage or a photochemical cleavage.
Claim 11
Dependent Claim
50 words
The method according to claim 5 in which the detection of step (c) is of a biological activity selected from the group consisting of cytotoxicity, antitumor activity, antibacterial activity, antiviral activity, antifungal activity, anti-parasite activity, growth factor activity, growth inhibitory activity, hormone activity, neurotransmitter activity, immunomodulator activity and regulatory activity.
Claim 12
Dependent Claim
89 words
A method for determining the chemical structure of a bio-oligomer which inhibits an enzyme catalyzed reaction comprising: (a) generating a bio-oligomer library of claim 1 in which the solid phase support is modified; (b) releasing a portion of the bio-oligomers from the solid phase support/bio-oligomer combination in situ; (c) detecting inhibition of the enzyme catalyzed reaction of interest in situ; (d) isolating a solid phase support/bio-oligomer combination detected in step (c); (e) determining the chemical structure of the bio-oligomer remaining on the solid phase support/bio-oligomer isolated in step (d).
Claim 13
Independent Claim
262 words
A method for determining the chemical structure of a bio-oligomer ligand for an acceptor molecule comprising the steps of: (a) introducing, to a bio-oligomer library comprising a multiplicity of solid phase supports, wherein a single deprotected bio-oligomer species is attached to each solid phase support, and which the library is prepared by a method comprising repeating k times, wherein k is at least three, the steps of: (i) providing at least two aliquots of a solid phase support said supports having a reactive site to which a species of subunit of the bio-oligomer can be covalently coupled; (ii) separately introducing a species of subunits of the bio-oligomers to each of the aliquots of solid phase supports such that a different subunit is introduced to each aliquot, at least one of said subunits having a protecting group or a plurality of protecting groups; (iii) completely covalently coupling the subunit to the reactive sites of the solid phase support; (iv) thoroughly mixing and deprotecting the aliquots of the solid phase supports whereby a reactive site is provided; and, after repeating steps (ii) through (iv) k times, a final step of removing any protecting groups such that the deprotected bio-oligomer remains covalently attached to the solid phase supports, an acceptor molecule of interest such that said acceptor molecule will recognize and bind to one or more solid phase support/bio-oligomer species within the library; (b) isolating a solid phase support/bio-oligomer combination that exhibits binding with the acceptor molecule; and (c) determining the chemical structure of the bio-oligomer of the solid phase support/bio-oligomer isolated in step (b).
Claim 14
Independent Claim
262 words
A method for determining the chemical structure of a bio-oligomer ligand for an acceptor molecule comprising the steps of: (a) introducing, to a bio-oligomer library comprising a multiplicity of solid phase supports, wherein a single deprotected bio-oligomer species is attached to each solid phase support, and which the library is prepared by a method comprising repeating k times, wherein k is at least three, the steps of: (i) providing at least two aliquots of a solid phase support said supports having a reactive site to which a species of subunit of the bio-oligomer can be covalently coupled; (ii) separately introducing a species of subunits of the bio-oligomers to each of the aliquots of solid phase supports such that a different subunit is introduced to each aliquot, at least one of said subunits having a protecting group or a plurality of protecting groups; (iii) completely covalently coupling the subunit to the reactive sites of the solid phase support; (iv) thoroughly mixing and deprotecting the aliquots of the solid phase supports whereby a reactive site is provided; and, after repeating steps (ii) through (iv) k times, a final step of removing any protecting groups such that the deprotected bio-oligomer remains covalently attached to the solid phase supports, an acceptor molecule of interest such that said acceptor molecule will recognize and bind to one or more solid phase support/bio-oligomer species within the library; (b) isolating a solid phase support/bio-oligomer combination that exhibits binding with the acceptor molecule; and (c) determining the chemical structure of the bio-oligomer of the solid phase support/bio-oligomer isolated in step (b).
Claim 15
Dependent Claim
28 words
The method according to claim 1, 5, 10, or 11 in which the subunits are selected from the group consisting of amino acids, amino acid analogs, and peptidomimetics.
Claim 16
Dependent Claim
32 words
The method according to claim 1, 5, 10, or 11 in which the subunits are linked by a bond selected from the group consisting of amide, ester, ether bonds and combinations thereof.
References Cited (Backward Citations)
US4392997A
Cited
US4618598A
Cited
US4703008A
Cited
US4555101A
Cited
US4590003A
Cited
US4569792A
Cited
US4625014A
Cited
WO1986000991A1
Cited
US5194392A
Cited
US4798787A
Cited
US4705777A
Cited
US4863857A
Cited
US4631211A
Cited
WO1986006487A1
Cited
US4833092A
Cited
US4784685A
Cited
US4833072A
Cited
US4780421A
Cited
US4837304A
Cited
WO1989003430A1
Cited
WO1989009088A1
Cited
US5010175A
Cited
US4988625A
Cited
EP0383620A2
Cited
US5182366A
Cited
US5510240A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-01-11 | 2002-07-13 | 2003-01-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-01-11 | 2006-07-13 | 2007-01-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-01-11 | 2010-07-13 | 2011-01-12 | $7700.00 | Window Closed / Lapsed |